Neurocrine Biosciences



Ebit تغيير تاريخ
AbbVie USD 5.65B 407M 2025-03
Acadia Pharmaceuticals USD 19.29M 12.3M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 92.98M 79.19M 2025-06
Alnylam Pharmaceuticals USD 4.89M 13.19M 2025-06
Amgen USD 3.6B 434M 2025-03
Biogen USD 816.6M 233.8M 2025-06
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
Dynavax Technologies USD -23630000 22M 2025-03
Exelixis USD 215.68M 28.82M 2025-07
Gilead Sciences USD 2.89B 221M 2025-03
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Incyte USD 310.82M 27.18M 2025-06
Ionis Pharmaceuticals USD 144.78M 290.78M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Pfizer USD 5.93B 1.31B 2025-03
Prothena USD -64897000 1.62M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Repligen USD 5.96M 17.45M 2025-06
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Teva Pharmaceutical Industries USD 946M 222M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12


Neurocrine Biosciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.